InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Farquharson Andrew, Director. Director active across 1 companies, notably Rani Therapeutics Holdings, Inc.. Aggregated, 3 filings have been recorded. The latest transaction was disclosed on 7 March 2022 (C). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
02,309,490 shares0
Class B Common Stock
SEC:0001179110-22-002127:0·
0827,467 shares0
Class A Common Stock
SEC:0001209191-22-007637·
0827,467 shares0
Class A Common Stock
SEC:0001209191-22-007637:0·
3 of 3 declarations
About Farquharson Andrew
Andrew Farquharson is a Director at Rani Therapeutics Holdings, Inc. He plays a key role in the governance of the company, bringing his experience and knowledge in the biotechnology sector. His involvement helps guide strategic decisions.
